content

Antihypertensive drug Micatrio combination tablets launch in Japan

Nippon Boehringer Ingelheim Co., Ltd. and Astellas Pharma Inc. announced that the companies have newly launched โ€œMicatrioยฎCombination Tablets,โ€ a combination drug of โ€œMicardisยฎ Tabletsโ€...

AbbVie and Eisai Subsidiary EA Pharma Commence Co-promotion of Fully Human Anti-TNF-a Monoclonal Antibody HUMIRAยฎ in the Field of Gastrointestinal Disease

AbbVie GK announced that EA Pharma and AbbVie will commence the co-promotion of fully human anti-TNF-ฮฑ monoclonal antibody HUMIRAยฎ for indications in the field...

Biogen Releases TECFIDERA data confirm strong, sustained efficacy in newly diagnosed MS Patients

World pharma today/Drug Research/-Biogen unveiled new TECFIDERAยฎ (dimethyl fumarate) research that reinforces its strong and sustained efficacy in newly diagnosed relapsing-remitting multiple sclerosis (RRMS)...

Chugai and Two Cells Co Ltd Announce a Licensing agreement for “gMSCยฎ1,” a Regenerative Cellular Medicine for Chondrogenesis in the Knee

Chugai Pharma and TWO CELLS Co Ltd announced that on April 25, 2016, both companies concluded a licensing agreement regarding gMSCยฎ1, a regenerative cellular...

Nplate Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia

Amgen announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate in children with symptomatic immune thrombocytopenia. ...

New Data Reaffirm Positive Benefit-Risk Balance of Bayerโ€™s Xareltoยฎ in Patients with Atrial Fibrillation in Daily Clinical Practice

Bayer AG and its development partner Janssen Pharmaceuticals, Inc announced results from a new real-world study, REVISIT-US.ย  In REVISIT-US reduced rates...

Kanuma receives marketing approval in Japan for Treatment of Patients with Lysosomal Acid Lipase Deficiency

Alexion Pharmaceuticals, Inc announced that Japanโ€™s Ministry of Health, Labour and Welfare has approved Kanuma for the treatment of patients of all ages in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read